SCHEMBL7832083

SCHEMBL7832083

Cc1ccnc2[nH]c(CO)nc12

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CCR1 P32246 1/20 0.34
CCR5 P51681 1/20 0.34
CCR8 P51685 1/20 0.34
CCNB2 O95067 2/20 0.34
CDK1 P06493 2/20 0.34
CCNB1 P14635 2/20 0.34
GSK3A P49840 2/20 0.34
GSK3B P49841 2/20 0.34
CDK5 Q00535 2/20 0.34
CDK5R1 Q15078 2/20 0.34
CCNB3 Q8WWL7 2/20 0.34
PARP1 P09874 1/20 0.33
PARP14 Q460N5 1/20 0.33
PARP11 Q9NR21 1/20 0.33
PARP2 Q9UGN5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4370028 0.84 ADORA1 (0.41) CCR1CCR5CCR8CDK1GSK3A
SCHEMBL28836229 0.83 CCR1 (0.34) CCR1CCR5CCR8CCNB2CDK1
Hydrochloric Acid SCHEMBL28836198 0.81 CYP1A2 (0.35) CCR1CCR5CCR8CCNB2CDK1
SCHEMBL4370037 0.81 NOS2 (0.41) KDM4ECCR1CCR5CCR8CCNB2
SCHEMBL3950341 0.80 GSK3B (0.38) KDM4ECCR1CCR5CCR8CCNB2
SCHEMBL6317646 0.79 LRRK2 (0.33) MEN1KMT2ACCR1CCR5CCR8
SCHEMBL8875881 0.79 GSK3B (0.44) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL8214129 0.78 CCNB2 (0.40) KMT2ACCNB2CDK1CCNB1GSK3A
SCHEMBL21620456 0.77 CCNB2 (0.40) CCR1CCR5CCR8CCNB2CDK1
SCHEMBL1665498 0.76 PARP1 (0.42) CCR1CCR5CCR8CCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed